» Articles » PMID: 23268665

Continuous Renal-replacement Therapy for Acute Kidney Injury

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2012 Dec 28
PMID 23268665
Citations 66
Authors
Affiliations
Soon will be listed here.
Citing Articles

Levetiracetam dosing in continuous renal replacement therapy: A systematic review and development of a novel pharmacokinetic model to optimise dosing in critically ill patients. Do recommended doses achieve therapeutic drug concentrations?.

Sweatman J, Al-Mahdi S, Lonsdale D, Leaver S, Rhodes A J Intensive Care Soc. 2025; :17511437251320557.

PMID: 40013239 PMC: 11851601. DOI: 10.1177/17511437251320557.


Hemoadsorption in Multiorgan Failure Due to Viscerocutaneous Loxoscelism.

Valenzuela Cordova R, Rivera Estrella D, Bernardo J, Jimenez D, Rodriguez Tudero C, Elias R Medicina (Kaunas). 2025; 61(1).

PMID: 39859124 PMC: 11766656. DOI: 10.3390/medicina61010143.


Hydrogel-Mediated Local Delivery of Induced Nephron Progenitor Cell-Sourced Molecules as a Cell-Free Approach for Acute Kidney Injury.

Park K, Gao W, Zheng J, Oh K, Kim I, You S Int J Mol Sci. 2024; 25(19).

PMID: 39408943 PMC: 11477367. DOI: 10.3390/ijms251910615.


Transitions and Long-Term Clinical Outcomes in Patients Admitted in Intensive Care Units Receiving Continuous Renal Replacement Therapy.

Valdenebro M, Portoles J, Serrano Salazar M, Munoz Sanchez A, Alameda-Aguado I, Martin Rodriguez L J Clin Med. 2024; 13(17).

PMID: 39274298 PMC: 11396298. DOI: 10.3390/jcm13175085.


Reimagining critical care: Trends and shifts in 21 century medicine.

Doppalapudi S, Khan B, Adrish M World J Crit Care Med. 2024; 13(3):94020.

PMID: 39253310 PMC: 11372510. DOI: 10.5492/wjccm.v13.i3.94020.